(Q46510361)

22 December 2017

title

Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection (English)

1 reference

22 December 2017

1 reference

Cai H

1

1 reference

22 December 2017

Tian X

2

1 reference

22 December 2017

Hu XD

3

1 reference

22 December 2017

Li SX

4

1 reference

22 December 2017

Yu DH

5

1 reference

22 December 2017

Zhu YX

6

1 reference

22 December 2017

language of work or name

English

0 references

publication date

14 April 2005

1 reference

22 December 2017

number of pages

9

1 reference

inferred from page(s)

published in

Vaccine

1 reference

22 December 2017

volume

23

1 reference

22 December 2017

issue

30

1 reference

22 December 2017

page(s)

3887-3895

1 reference

22 December 2017

Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

A review of M. bovis BCG protection against TB in cattle and other animals species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Protection against tuberculosis by a plasmid DNA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

The immunogenicity of single and combination DNA vaccines against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Therapy of tuberculosis in mice by DNA vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Recognition of a common mycobacterial T-cell epitope in MPB59 of Mycobacterium bovis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Bovine tuberculosis: immune responses in the peripheral blood and at the site of active disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Protection of mice with a divalent tuberculosis DNA vaccine encoding antigens Ag85B and MPT64.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Immunogenicity and protective efficacy study using combination of four tuberculosis DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Cloning and B-cell-epitope mapping of MPT64 from Mycobacterium tuberculosis H37Rv

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

7 January 2021

inferred from DOI database lookup

Mapping of the delayed-type hypersensitivity-inducing epitope of secreted protein MPT64 from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

7 January 2021

inferred from DOI database lookup

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2005.03.025

1 reference

22 December 2017

PubMed ID

15917109

1 reference

22 December 2017